Long-term living conditions of patients after Non-Hodgkin's Lymphoma in France
Living Conditions After Non-Hodgkin's Lymphoma in France
This study looks at how people in France who have had Non-Hodgkin's Lymphoma are doing in their everyday lives and how long they live after their diagnosis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3209 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire Dijon Academic / other |
| Locations | 1 site (Dijon) |
| Trial ID | NCT05583318 on ClinicalTrials.gov |
What this trial studies
This project investigates the long-term living conditions of patients who have been diagnosed with diffuse large B-cell lymphoma or follicular lymphoma in France. It utilizes population data from specialized hematology registries in Côte-d'Or, Gironde, and Basse-Normandie to analyze survival rates and quality of life indicators. The study includes a survival analysis based on initial data and follows up with questionnaires sent to eligible patients to gather further insights into their living conditions post-diagnosis.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with follicular lymphoma or diffuse large B-cell lymphoma between 2010 and 2018 who are alive at the time of the study.
Not a fit: Patients with other forms of malignant hemopathies or those who are minors will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term outcomes and quality of life for patients after treatment for Non-Hodgkin's Lymphoma.
How similar studies have performed: This approach is innovative as it focuses on long-term living conditions and survival indicators for Non-Hodgkin's Lymphoma, which has not been extensively studied in this manner before.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis period 2010-2018, according to the 2008 WHO ICD-O-3 classification, from the hematological malignancy registries of Côte-d'Or, Gironde, Basse-Normandie * Patients with a diagnosis of follicular lymphoma (9690/3, 9691/3, 9695/3, 9698/3, 9597/3) * Patients with a diagnosis of diffuse large B-cell lymphoma (9678/3, 9679/3, 9680/3, 9684/3, 9688/3, 9712/3, 9735/3, 9737/3, 9738/3) * For Part 2: Individuals alive at the date of vital status update Non-inclusion criteria: * Other forms of malignant hemopathies at diagnosis, * Minors. Exclusion Criteria: * Person under a legal protection measure (curatorship, guardianship) * Person under a legal protection measure (guardianship, tutorship) * Pregnant, parturient or breastfeeding women * Major incapable or unable to express his consent * Person who did not return the questionnaires following the 1-month follow-up, or patient who expressed refusal to participate.
Where this trial is running
Dijon
- Chu Dijon Bourgogne — Dijon, France (Recruiting)
Study contacts
- Study coordinator: Marc MAYNADIE
- Email: Marc.Maynadie@u-bourgogne.fr
- Phone: 03 80 39 30 48
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.